trial
as of 2026-07-01Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia
NCTId NCT06501339
at a glance
Phase 4 · Not Yet Recruiting
Enrollment 40 (estimated)
Sponsored by All India Institute of Medical Sciences, Bhubaneswar
Primary completion 2025-10-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Not Yet Recruiting
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2024-08-10
Primary completion
2025-10-31
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Drugs
Sponsors
Investigators
1
Rituparna Maiti, MDStudy Director
Sites
0 total
Facts & assertions
4 sourced
Enrollment
40
Phase
PHASE4
Primary Completion Date
2025-10-31
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
drug
lead_sponsor
indication
indication
indication
investigator
person